- Home
- IRWD vs DOUG Comparison
IRWD vs DOUG Comparison
Compare IRWD & DOUG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IRWD
- DOUG
- Stock Information
- Founded
- IRWD 1998
- DOUG 1911
- Country
- IRWD United States
- DOUG United States
- Employees
- IRWD N/A
- DOUG N/A
- Industry
- IRWD Biotechnology: Pharmaceutical Preparations
- DOUG Building operators
- Sector
- IRWD Health Care
- DOUG Real Estate
- Exchange
- IRWD Nasdaq
- DOUG Nasdaq
- Market Cap
- IRWD 251.8M
- DOUG 219.1M
- IPO Year
- IRWD 2010
- DOUG N/A
- Fundamental
- Price
- IRWD $2.03
- DOUG $2.43
- Analyst Decision
- IRWD Buy
- DOUG
- Analyst Count
- IRWD 5
- DOUG 0
- Target Price
- IRWD $4.94
- DOUG N/A
- AVG Volume (30 Days)
- IRWD 1.4M
- DOUG 382.0K
- Earning Date
- IRWD 11-04-2025
- DOUG 11-04-2025
- Dividend Yield
- IRWD N/A
- DOUG N/A
- EPS Growth
- IRWD N/A
- DOUG N/A
- EPS
- IRWD N/A
- DOUG N/A
- Revenue
- IRWD $308,519,000.00
- DOUG $1,030,928,000.00
- Revenue This Year
- IRWD N/A
- DOUG $17.61
- Revenue Next Year
- IRWD N/A
- DOUG N/A
- P/E Ratio
- IRWD N/A
- DOUG N/A
- Revenue Growth
- IRWD N/A
- DOUG 6.67
- 52 Week Low
- IRWD $0.53
- DOUG $1.48
- 52 Week High
- IRWD $5.13
- DOUG $3.20
- Technical
- Relative Strength Index (RSI)
- IRWD 68.00
- DOUG 41.12
- Support Level
- IRWD $1.76
- DOUG $2.25
- Resistance Level
- IRWD $2.23
- DOUG $2.89
- Average True Range (ATR)
- IRWD 0.16
- DOUG 0.13
- MACD
- IRWD 0.04
- DOUG -0.01
- Stochastic Oscillator
- IRWD 75.43
- DOUG 28.48
About IRWD Ironwood Pharmaceuticals Inc.
Ironwood Pharmaceuticals Inc is a specialty and generic drug manufacturing company that operates a human therapeutics segment. The company is focused on advancing product opportunities in areas of large unmet need, including irritable bowel syndrome with constipation, chronic idiopathic constipation, hyperuricemia associated with uncontrolled gout, uncontrolled gastroesophageal reflux disease, and vascular and fibrotic diseases. The company considers collaborative licenses, commercial agreements, and acquisition investment to be potential components of its operational growth plan for expanding its research, development, manufacturing, and marketing capabilities.
About DOUG Douglas Elliman Inc.
Douglas Elliman Inc is a real estate company. It offers sales, rentals, and new development to mortgages and title insurance, among other services related to real estate. Business is engaged in two operating segments Real Estate Brokerage and Corporate and other. The firm generates income from Commission and other brokerage revenue from existing home sales, Commission and other brokerage income from development marketing, Property management revenue and Title fees. It derives revenue from Real Estate Brokerage segment.